Oxford Biomedica plc reiterated earnings guidance for the year 2024. For the year, the company expected total Group revenues of between £126 million and £134 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
312 GBX | -0.95% | +1.79% | +41.82% |
Jun. 18 | EARNINGS AND TRADING: Cordel thrilled by Middle East contract win | AN |
May. 09 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.82% | 399M | |
+15.07% | 122B | |
+19.91% | 113B | |
+8.24% | 22.84B | |
-20.29% | 20.72B | |
-16.19% | 16.51B | |
-13.11% | 16.39B | |
-44.35% | 15.83B | |
+1.50% | 13.49B | |
+65.53% | 11.67B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024